Asbestosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Conditions:   Triple Negative Breast Cancer;   Hormone-Resistant Breast Cancer;   Non Small Cell Lung Cancer;   Mesothelioma Intervention:   Drug: AG-01 Compound Sponsors:   A&G  Pharmaceutical Inc.;   University of Maryland Greenebaum Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2022 Category: Research Source Type: clinical trials